Literature DB >> 18633756

Gender-specific differences in hypertension prevalence, treatment, control, and associated conditions among the elderly: data from a Greek population.

Ilias Ninios1, Vlasios Ninios, Fotini Lazaridou, Kyriakos Dimitriadis, Olga Kerasidou, George Louridas.   

Abstract

PURPOSE: In the present study we sought to assess the gender-specific prevalence, treatment rates, and control of hypertension, as well as to identify its associated conditions and additional cardiovascular (CV) risk factors, in a Greek population aged > or = 65 years old.
METHODS: This is a population-based study including a clinical interview, an ECG recording, and blood pressure (BP) measurements by sphygmomanometer.
RESULTS: The overall prevalence of hypertension was 83.3%, higher in females and increasing with age. In males, hypertension was independently associated with increased body mass index (BMI), a history of stroke, and myocardial infarction, while in females increased age, BMI, and a history of diabetes were independently associated with hypertension. A considerable proportion of hypertensives were treated (77.3%), while an effective control of BP was achieved in 42.5% of treated subjects. Despite the fact that hypertension treatment rates did not differ between the genders, control rates were lower among females. Finally, more hypertensive females presented additional CV risk factors than normotensives.
CONCLUSION: Elderly females exhibit a higher prevalence of hypertension and are characterized by lower hypertension control compared to hypertensive males.

Entities:  

Mesh:

Year:  2008        PMID: 18633756     DOI: 10.1080/10641960802269943

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  1 in total

1.  Evaluation of the National Kidney Foundation of Hawai'i's Kidney Early Detection Screening program.

Authors:  Merle R Kataoka-Yahiro; Kamomilani Anduha Wong; Jill Tamashiro; Victoria Page; Julaine Ching; Dongmei Li
Journal:  Hawaii J Med Public Health       Date:  2012-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.